Addus HomeCare (NASDAQ:ADUS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Macquarie in a research report issued on Thursday,Benzinga reports. They currently have a $129.00 price target on the stock. Macquarie’s price target suggests a potential upside of 34.70% from the company’s current price.
A number of other equities research analysts have also commented on ADUS. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday. Oppenheimer upped their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Stephens decreased their target price on Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $132.78.
Read Our Latest Research Report on Addus HomeCare
Addus HomeCare Stock Down 1.0 %
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, equities research analysts expect that Addus HomeCare will post 4.59 EPS for the current year.
Insider Buying and Selling
In other news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by company insiders.
Institutional Trading of Addus HomeCare
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Capital Research Global Investors purchased a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $51,149,000. American Century Companies Inc. boosted its holdings in Addus HomeCare by 695.8% during the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock worth $35,643,000 after acquiring an additional 248,613 shares during the last quarter. Bank of America Corp DE boosted its holdings in Addus HomeCare by 273.6% during the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock worth $21,945,000 after acquiring an additional 128,211 shares during the last quarter. Wasatch Advisors LP grew its stake in shares of Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after acquiring an additional 110,010 shares in the last quarter. Finally, TimesSquare Capital Management LLC raised its holdings in shares of Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after purchasing an additional 78,835 shares during the last quarter. 95.35% of the stock is owned by institutional investors.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- What is Forex and How Does it Work?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- How to invest in marijuana stocks in 7 steps
- 5 Best Gold ETFs for March to Curb Recession Fears
- 5 Top Rated Dividend Stocks to Consider
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.